CheckMyRecalls

Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride…

Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride Tablets

Published
16 Apr 2025
Units affected
3144 bottles, pack size: 100's Count
Agency
FDA
Country
United States

The hazard

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot #: Z400069, Exp.: 12/31/2025
Distribution
Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 16 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.